Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC | 60,000 | reported | 16 Jan 2026 | tx 15+389,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jan 2026 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 23 Jan 2025 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 24 Dec 2024 | PURCHASE | GALECTIN THERAPEUTICS INC | 10,000 | 0.82 USD | |
| 23 Aug 2024 | PURCHASE | GALECTIN THERAPEUTICS INC | 1,000 | 2.30 USD | |
| 22 Aug 2024 | PURCHASE | GALECTIN THERAPEUTICS INC | 741 | 2.30 USD | |
| 23 Aug 2024 | PURCHASE | GALECTIN THERAPEUTICS INC | 1,759 | 2.30 USD | |
| 30 Apr 2024 | PURCHASE | GALECTIN THERAPEUTICS INC | 1,000 | 3.52 USD | first after silence |
| 24 Jan 2024 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 50,000 | 0.00 USD | deriv |
| 26 Jan 2023 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 28 Jul 2022 | PURCHASE | GALECTIN THERAPEUTICS INC | 5,000 | 2.50 USD | |
| 04 Apr 2022 | PURCHASE | GALECTIN THERAPEUTICS INC | 5,000 | 1.61 USD | |
| 24 Jan 2022 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 14 Jan 2022 | PURCHASE | GALECTIN THERAPEUTICS INC | 5,000 | 2.02 USD | |
| 25 Mar 2021 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 25 Mar 2021 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 70,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Apr 2024.